Treace Medical Concepts, Inc. (TMCI)

4.28 +0.01 (+0.23%) USD  |  NASDAQ  |  Nov 03, 16:00
4.27 -0.01 (-0.23%) After-Hours: 20:00
More

Treace Medical Concepts EPS Diluted (Quarterly) : -0.244 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.244
March 31, 2026 -0.2781
December 31, 2025 -0.1471
September 30, 2025 -0.2564
June 30, 2025 -0.2761
March 31, 2025 -0.2541
December 31, 2024 -0.008
September 30, 2024 -0.2468
June 30, 2024 -0.3416
March 31, 2024 -0.3022
December 31, 2023 -0.1018
September 30, 2023 -0.2846
June 30, 2023 -0.1999
March 31, 2023 -0.2291
December 31, 2022 -0.0794
Date Value
September 30, 2022 -0.2189
June 30, 2022 -0.3116
March 31, 2022 -0.1648
December 31, 2021 -0.1222
September 30, 2021 -0.1216
June 30, 2021 -0.0971
March 31, 2021 -0.0506
December 31, 2020 0.047
September 30, 2020 -0.055
June 30, 2020 -0.0417
March 31, 2020 -0.0345
December 31, 2019 0.0337
September 30, 2019 -0.0558
June 30, 2019 -0.0336
March 31, 2019 -0.0401

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Tactile Systems Technology, Inc. 0.3107
Abbott Laboratories 0.5293
AngioDynamics, Inc. -0.1689
Alphatec Holdings, Inc. -0.0348
AtriCure, Inc. 0.1832

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -15.87M
Revenue (Quarterly) 45.38M
Total Expenses (Quarterly) 61.25M
Enterprise Value 306.64M
Gross Profit Margin (Quarterly) 78.47%
Profit Margin (Quarterly) -34.98%
Earnings Yield -21.63%
Normalized Earnings Yield -20.93